Murnane KS[au] - Search Results

Year	Number of Results
2007	1
2008	2
2009	3
2010	4
2011	4
2012	3
2013	3
2014	1
2015	1
2016	1
2017	2
2018	6
2019	15
2020	8
2021	9
2022	4

1

Naltrexone Implant for Opioid Use Disorder.

Edinoff AN, Nix CA, Orellana CV, StPierre SM, Crane EA, Bulloch BT, Cornett EM, Kozinn RL, Kaye AM, Murnane KS, Kaye AD. Edinoff AN, et al. Among authors: murnane ks. Neurol Int. 2021 Dec 30;14(1):49-61. doi: 10.3390/neurolint14010004. Neurol Int. 2021. PMID: 35076607 Free PMC article. Review.

2

Young at heart? Drugs of abuse cause early-onset cardiovascular disease in the young.

Scott ML, Murnane KS, Orr AW. Scott ML, et al. Among authors: murnane ks. Heart. 2021 Apr;107(8):604-606. doi: 10.1136/heartjnl-2020-318856. Epub 2021 Feb 15. Heart. 2021. PMID: 33589426 Free PMC article. No abstract available.

3

Omega-3 Fatty Acids as Druggable Therapeutics for Neurodegenerative Disorders.

Chitre NM, Moniri NH, Murnane KS. Chitre NM, et al. Among authors: murnane ks. CNS Neurol Disord Drug Targets. 2019;18(10):735-749. doi: 10.2174/1871527318666191114093749. CNS Neurol Disord Drug Targets. 2019. PMID: 31724519 Free PMC article. Review.

4

Neuroimaging and drug taking in primates.

Murnane KS, Howell LL. Murnane KS, et al. Psychopharmacology (Berl). 2011 Jul;216(2):153-71. doi: 10.1007/s00213-011-2222-7. Epub 2011 Mar 1. Psychopharmacology (Berl). 2011. PMID: 21360099 Free PMC article. Review.

5

The behavioral pharmacology of hallucinogens.

Fantegrossi WE, Murnane KS, Reissig CJ. Fantegrossi WE, et al. Among authors: murnane ks. Biochem Pharmacol. 2008 Jan 1;75(1):17-33. doi: 10.1016/j.bcp.2007.07.018. Epub 2007 Jul 20. Biochem Pharmacol. 2008. PMID: 17977517 Free PMC article. Review.

6

The renaissance in psychedelic research: What do preclinical models have to offer.

Murnane KS. Murnane KS. Prog Brain Res. 2018;242:25-67. doi: 10.1016/bs.pbr.2018.08.003. Epub 2018 Oct 5. Prog Brain Res. 2018. PMID: 30471682 Review.

7

The synthetic cathinone 3,4-methylenedioxypyrovalerone increases impulsive action in rats.

Hyatt WS, Hirsh CE, Russell LN, Chitre NM, Murnane KS, Rice KC, Fantegrossi WE. Hyatt WS, et al. Among authors: murnane ks. Behav Pharmacol. 2020 Jun;31(4):309-321. doi: 10.1097/FBP.0000000000000548. Behav Pharmacol. 2020. PMID: 32101987

8

The serotonin 5-HT_2C receptor and the non-addictive nature of classic hallucinogens.

Canal CE, Murnane KS. Canal CE, et al. Among authors: murnane ks. J Psychopharmacol. 2017 Jan;31(1):127-143. doi: 10.1177/0269881116677104. Epub 2016 Nov 15. J Psychopharmacol. 2017. PMID: 27903793 Free PMC article. Review.

9

Examination of xylene exposure in the U.S. Population through biomonitoring: NHANES 2005-2006, 2011-2016.

De Jesús VR, Milan DF, Yoo YM, Zhang L, Zhu W, Bhandari D, Murnane KS, Blount BC. De Jesús VR, et al. Among authors: murnane ks. Biomarkers. 2021 Feb;26(1):65-73. doi: 10.1080/1354750X.2020.1861100. Epub 2020 Dec 17. Biomarkers. 2021. PMID: 33284648 Free PMC article.

10

Nanoparticle encapsulated oxytocin increases resistance to induced seizures and restores social behavior in Scn1a-derived epilepsy.

Wong JC, Shapiro L, Thelin JT, Heaton EC, Zaman RU, D'Souza MJ, Murnane KS, Escayg A. Wong JC, et al. Among authors: murnane ks. Neurobiol Dis. 2021 Jan;147:105147. doi: 10.1016/j.nbd.2020.105147. Epub 2020 Oct 25. Neurobiol Dis. 2021. PMID: 33189882 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results